Clinical Trial Update: Study to Evaluate Efficacy and Safety of MP1032 in Patients With Chronic Plaque Psoriasis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating MP1032 for chronic plaque psoriasis has completed, and results have been posted on ClinicalTrials.gov.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• MP1032

Snippet

Sponsor: MetrioPharm AG | Conditions: Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2024-11-22